Girardi G, Lingo J, Fleming S, Regal J
Front Immunol. 2020; 11:1681.
PMID: 32849586
PMC: 7411130.
DOI: 10.3389/fimmu.2020.01681.
Walachowski S, Tabouret G, Foucras G
PLoS One. 2016; 11(2):e0148464.
PMID: 26840954
PMC: 4739705.
DOI: 10.1371/journal.pone.0148464.
Bose N, Chan A, Guerrero F, Maristany C, Qiu X, Walsh R
Front Immunol. 2013; 4:230.
PMID: 23964276
PMC: 3740326.
DOI: 10.3389/fimmu.2013.00230.
Evans R, Bingham M, WEISER R
J Exp Med. 2009; 117(4):647-61.
PMID: 19867227
PMC: 2137614.
DOI: 10.1084/jem.117.4.647.
Hinz C, Picken M, Lepow I
J Exp Med. 2009; 113(1):193-218.
PMID: 19867184
PMC: 2137331.
DOI: 10.1084/jem.113.1.193.
Loa loa Microfilariae evade complement attack in vivo by acquiring regulatory proteins from host plasma.
Haapasalo K, Meri T, Jokiranta T
Infect Immun. 2009; 77(9):3886-93.
PMID: 19528206
PMC: 2738024.
DOI: 10.1128/IAI.01583-08.
Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement.
Kimura Y, Miwa T, Zhou L, Song W
Blood. 2007; 111(2):732-40.
PMID: 17916747
PMC: 2200840.
DOI: 10.1182/blood-2007-05-089821.
A STUDY OF THE RELATIONSHIP OF THE NORMAL BACTERICIDAL ACTIVITY OF HUMAN SERUM TO BACTERIAL INFECTION.
Roantree R, RANTZ L
J Clin Invest. 1960; 39(1):72-81.
PMID: 16695824
PMC: 290665.
DOI: 10.1172/JCI104029.
NEUTRALIZATION OF BACTERIOPHAGE BY THE PROPERDIN SYSTEM.
Van Vunakis H, Barlow J, Levine L
Proc Natl Acad Sci U S A. 1956; 42(7):391-4.
PMID: 16589874
PMC: 534234.
DOI: 10.1073/pnas.42.7.391.
Inactivation of endotoxin by a humoral component. VI. Two separate systems required for viable and killed Salmonella typhosa.
Landy M, TRAPANI R, Rosen F
J Clin Invest. 1960; 39:352-63.
PMID: 14413830
PMC: 441813.
DOI: 10.1172/JCI104046.
[Experimental contribution to the problem of inactivation of bacteriophages by the properdin system].
HUSMANN K
Z Hyg Infektionskr. 1959; 146:89-96.
PMID: 14405590
[SERUM PROPERDIN IN THE COURSE OF VIRUS DISEASES. DETERMINED ON AN EXAMPLE OF HEPATITIS].
SCHEIFFARTH F, TYMPNER K, FRENGER W
Klin Wochenschr. 1964; 42:379-81.
PMID: 14214532
DOI: 10.1007/BF01488633.
THE RELATION BETWEEN THE BACTERICIDAL ACTIVITY OF COMPLEMENT AND THE CHARACTER OF THE BACTERIAL SURFACES.
STERZL J, PESAK V, Kostka J, Jilek M
Folia Microbiol (Praha). 1964; 89:284-98.
PMID: 14208479
DOI: 10.1007/BF02873307.
Effect of proflavine on the synthesis of adenovirus, type 5, and associated soluble antigens.
Wilcox W, Ginsberg H
J Bacteriol. 1962; 84:526-33.
PMID: 14000661
PMC: 277909.
DOI: 10.1128/jb.84.3.526-533.1962.
Accessory plasma factors involved in the bactericidal test for type-specific antibody to group A Streptococci. II. Human plasma cofactor (s) enhancing opsonization of encapsulated organisms.
STOLLERMAN G, RYTEL M, Ortiz J
J Exp Med. 1963; 117:1-17.
PMID: 13984363
PMC: 2180439.
DOI: 10.1084/jem.117.1.1.
Development of bactericidal properties against gram-negative organisms in the serum of young animals.
STERZL J, Kostka J, LANC A
Folia Microbiol (Praha). 1962; 7:162-74.
PMID: 13917025
DOI: 10.1007/BF02928237.
The effects of guinea-pig gamma globulins on capillary permeability and serum complement.
Davies G, LOWER J
Immunology. 1961; 4:289-300.
PMID: 13883825
PMC: 1424136.
Studies on the biologic relationship of endotoxin and other toxic proteins. I. Comparison of the properties of snake venom and endotoxin.
Condie R, Staab E, GOOD R
J Exp Med. 1962; 115:563-78.
PMID: 13880807
PMC: 2137499.
DOI: 10.1084/jem.115.3.563.
Purification and immunological characterization of types 4 and 5 adenovirus-soluble antigens.
Wilcox W, Ginsberg H
Proc Natl Acad Sci U S A. 1961; 47:512-26.
PMID: 13785230
PMC: 221481.
DOI: 10.1073/pnas.47.4.512.
[Experimental animal studies on the problem of natural resistance to bacterial infections. Part II. Treatment of staphylococcal sepis in protein-pretreated rats with antitoxic staphylococcal serum and the serum of healthy rats].
KIENITZ M, Ritzerfeld W, SEBERS R
Z Hyg Infektionskr. 1960; 147:28-37.
PMID: 13755850
